Related Experiment Video
Updated: Jul 7, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Gut microbes in Crohn's disease: getting to know you better?
Abstract:
Biomarkers in inflammatory bowel disease (IBD) are needed to help in disease diagnosis, prognosis, and assessment of disease activity. The best serologic markers to date measure antibody responses to normal commensal flora. These antibody responses can provide prognostic information as well as clues to disease pathogenesis. There remains room for additional biomarkers to clarify the diagnosis for certain patients with indeterminate colitis or small bowel Crohn's disease (CD) with protean manifestations. In this issue of the Journal, Adams and colleagues describe the presence of antibodies against Bacteroides vulgatus in CD patients. This additional marker may complement existing disease markers. Future studies should address whether these antibodies can help categorize patients with indeterminate colitis or predict severity of CD.
Related Concept Videos
Dysbiosis of the Gut Microbiota
Functions of the Gut Microbiota
Inflammatory Bowel Disease III: Crohn's Disease
Microbiota of the Stomach and Small Intestine
Introduction to the Human Microbiota
Microbiota of the Large Intestine
